Modeling and Simulation to Support Phase 2 Dose Selection for RG7652, a Fully Human Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9

Nageshwar R. Budha, Maya K. Leabman, Jin Y. Jin et al. · The AAPS Journal · 2015

Cited by 17 works. doi:10.1208/s12248-015-9750-8 Open-access PDF

Authors

References